Aspiration & Biopsy Needles Market By Product (Biopsy Needles and Aspiration Needles), By Procedure (Image-Guided Procedures and Nonimage-Guided Procedures), By Site (Bone & Bone Marrow, Breast, Colorectal, Kidney, Prostate, and Lung), By End User (Hospitals, Diagnostic & Imaging Centers, Research Laboratories, and Academic Institutions) – Global Analysis & Forecast 2020-2030
Report ID : 361 | Published Date : Jul 2020 | Pages : 160 | Region : Global | Report Code : MD-121
Aspiration & Biopsy Needles Market Introduction & Overview
A biopsy is a sample of tissue or cells taken from the body to diagnose an illness or to identify cancer. Needle or aspiration biopsy does not require surgery and a local anesthetic is sometimes utilized to numb the area under consideration. As it is a minimally invasive procedure, it rarely causes much discomfort and leaves no scar. The inserted needle is guided by imaging techniques such as real-time X-ray (fluoroscopy), Computed Tomography (CT), ultrasound, or Magnetic Resonance (MR) during the procedure. Fine-needle aspiration is often done on swellings or lumps located under the skin discovered during a doctor’s examination or imaging tests such as ultrasound, CT scan, and mammogram. Fine needle aspirations are most commonly performed to screen for cancer. They are mostly performed on areas such as the breast, thyroid gland, and lymph nodes in the neck, groin, or armpit. The pathology report provides information regarding the biopsied sample and helps the doctor in making informed decisions regarding treatment options.
The aspiration & biopsy needles market is driven by factors such as safety, minimal invasiveness as compared to open & closed surgical biopsies, less pain, high accuracy that is similar to surgical tissue removal, and less recovery time, allowing a patient to resume daily activities. Also, growing awareness regarding diseases and major players investing in R&D are adding to the growth of the aspiration & biopsy market. Moreover, increasing incidences and prevalence of cancer and technological advancements in imaging, such as x-rays for obtaining images at different angles, are expected to contribute to the aspiration & biopsy market.
However, the number of tissue samples obtained may not be sufficient and the biopsy may have to be repeated. This may hamper market growth to a certain extent.
The global aspiration & biopsy needles market can be segmented into product, procedure, site, end-user, and region.
Aspiration & Biopsy Needles Market By Product
Based on the product, the market can be segmented into biopsy needles and aspiration needles. The biopsy needles segment accounted for the largest market share owing to factors such as the increasing preference for least invasive procedures, less recovery time, less pain and increasing incidences & prevalence of cancer.
Aspiration & Biopsy Needles Market By Procedure
Based on the procedure, the market can be classified into image-guided procedures and nonimage-guided procedures. The image-guided procedures occupied the largest market share during the forecast period, owing to factors such as the utilization of specialized imaging equipment to guide the needle to the desired site and assistance in discovering abnormal spots, including cysts, nodules, and enlarged lymph nodes, deeper inside the body.
Aspiration & Biopsy Needles Market By Site
Based on the site, the market can be classified into bone & bone marrow, breast, colorectal, kidney, prostate, lung, and others. The breast segment accounted for the largest market share owing to factors, such as increasing breast cancer screening & diagnostic testing activities, growing breast cancer incidences and rising awareness regarding the condition.
Aspiration & Biopsy Needles Market By End User
Based on the end-user, the market can be classified into hospitals, diagnostic & imaging centers, research laboratories, and academic institutions. The hospital segment accounted for the largest share owing to factors such as growing economies, the increasing number of hospitals, growing healthcare expenditure and the preference for hospital-based biopsy.
Aspiration & Biopsy Needles Market By Region
Based on the region, the market can be segmented into North America, Europe, Asia-Pacific, and the Rest of the World (ROW). North America dominated the global aspiration & biopsy needles market owing to increasing investments in healthcare to improve the rate & accuracy of cancer diagnosis, investments in R&D to improve diagnostic procedures and technological advancements enabling the adoption of image-guided biopsies to take out a small sample of tissue or obtain images in different angles. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to the increasing incidences and prevalence of cancer, awareness regarding different diseases among people, increasing investments in the healthcare sector to ensure accurate diagnosis & treatment of diseases and the adoption of advanced technologies are supplementing the growth of the aspiration & biopsy needles market.
Aspiration & Biopsy Needles Market Prominent Players
Some of the key players operating in the aspiration & biopsy needles market include CONMED Corporation, BD, Cardinal Health, ARGON MEDICAL, Boston Scientific Corporation, INRAD Inc., HAKKO CO., LTD., Cook, Olympus America, Medtronic, and others.